SCHEMBL20289618

SCHEMBL20289618

C=CC(=O)N1CCN(C(CC2CC2)c2ccc(CNc3ncc4c(n3)N(CC)C(=O)OC4)cc2)CC1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 20/20 0.82
▸ IDH2 P48735 17/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205239 0.94 IDH1 (0.79) IDH1IDH2
SCHEMBL22591188 0.92 IDH1 (0.81) IDH1IDH2
SCHEMBL22879064 0.91 IDH1 (0.82) IDH1IDH2
Crelosidenib SCHEMBL29765374 0.90 IDH1 (1.00) IDH1IDH2
Crelosidenib SCHEMBL20271764 0.90 IDH1 (1.00) IDH1IDH2
Crelosidenib SCHEMBL20289768 0.90 IDH1 (1.00) IDH1IDH2
Crelosidenib SCHEMBL29427547 0.90 IDH1 (1.00) IDH1IDH2
Crelosidenib SCHEMBL20270338 0.90 IDH1 (1.00) IDH1IDH2
Crelosidenib SCHEMBL20270341 0.90 IDH1 (1.00) IDH1IDH2
SCHEMBL22591170 0.90 IDH1 (0.83) IDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141087-A1 COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR ELI LILLY AND COMPANY (US) 2023-07-27 — — WO disclosed
EP-3763717-B1 PYRIDO[4,3-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS LILLY CO ELI (US) 2023-03-08 — — EP disclosed
EP-3763717-A1 PYRIDO[4,3-D][1,3]OXAZIN-2-ONE AND PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS ELI LILLY AND CO. (US) 2021-01-13 — — EP disclosed
EP-3555105-B1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS LILLY CO ELI (US) 2020-10-28 — — EP disclosed
WO-2018111707-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS ELI LILLY AND COMPANY (US) 2018-06-21 — — WO disclosed
Send feedback